Investigating the Potential of NHE1 Inhibitors as Potential Adjuvant Therapies in the Treatment of Ovarian Cancer

被引：0
|
作者：
Corradi, Anna [1 ]
Wallert, Mark [1 ]
机构：
[1] Bemidji State Univ, Bemidji, MN USA
来源：
FASEB JOURNAL | 2020年 / 34卷
关键词：
D O I：
10.1096/fasebj.2020.34.s1.05783
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Farnesyltransferase inhibitors - Potential role in the treatment of cancer
    Cox, AD
    DRUGS, 2001, 61 (06) : 723 - 732
  • [42] PARP inhibitors in ovarian cancer: evidence, experience and clinical potential
    Evans, Tarra
    Matulonis, Ursula
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2017, 9 (04) : 253 - 267
  • [43] Potential of Integrin Inhibitors for Treating Ovarian Cancer: A Literature Review
    Kobayashi, Masaki
    Sawada, Kenjiro
    Kimura, Tadashi
    CANCERS, 2017, 9 (07)
  • [44] Investigating the Regulation of the Na plus -H plus Exchanger Isoform 1 (NHE1) by Palmitoylation and Phosphorylation
    Leffelman, Hannah
    Wallert, Mark
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2023, 299 (03) : S781 - S781
  • [45] Potential Role of NHE1 (Sodium-Hydrogen Exchanger 1) in the Cellular Dysfunction of Lactic Acidosis: Implications for Treatment (vol 57, pg 781, 2011)
    Wu, Dongmei
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2011, 57 (06) : 966 - 966
  • [46] PMPMEase inhibitors as potential therapies for castration-resistant prostate cancer
    Poku, Rosemary
    Amissah, Felix
    Duverna, Randolph
    Byron, Aguilar
    Lamango, Nazarius
    FASEB JOURNAL, 2014, 28 (01):
  • [47] Characterizing the role of the Na+-H+ Exchanger Isoform 1 (NHE1) in cell proliferation and migration in ovarian cancer cells.
    Manzella, Taylor M.
    Provost, Joseph J.
    Wallert, Mark A.
    FASEB JOURNAL, 2017, 31
  • [48] Fibronectin 1: A Potential Biomarker for Ovarian Cancer
    Bao, Huijing
    Huo, Qianyu
    Yuan, Qin
    Xu, Chen
    DISEASE MARKERS, 2021, 2021
  • [49] Emerging therapies: angiogenesis inhibitors for ovarian cancer
    Jackson, Amanda L.
    Eisenhauer, Eric L.
    Herzog, Thomas J.
    EXPERT OPINION ON EMERGING DRUGS, 2015, 20 (02) : 331 - 346
  • [50] Cyclooxygenase-1 is a potential target for prevention and treatment of ovarian epithelial cancer
    Daikoku, T
    Wang, DZ
    Tranguch, S
    Morrow, JD
    Orsulic, S
    DuBois, RN
    Dey, SK
    CANCER RESEARCH, 2005, 65 (09) : 3735 - 3744
12345